cjc-1295 with dac + ipamorelin (NO DAC) – Research Peptide CJC-1295 (No DAC) (5mg) /

Orforglipron is a pill

Some work remarkably well

peaks 24 hours post-dose, resolves by 810 hours Mild injection site reactions redness at subcutaneous injection site Contraindications Uncontrolled hypertension or cardiovascular disease Concurrent use of certain blood pressure medications evaluated at consultation Pregnancy or breastfeeding High cardiovascular risk assessed at baseline Dosing Limits & Hyperpigmentation Note Maximum one dose per 24 hours, maximum 8 doses per month

Improved nanocarrier technology targeting the CNS is a critical step towards treating disorders characterized by the coexistence of inflammation and oxidative stress where the immunologic properties of GSH show therapeutic benefit

NAC works by supplying the body with N-acetyl cysteine, a form of the amino acid cysteine that helps produce glutathione

The mechanism isn't fully elucidated but is thought to be related to the peptide's interaction with receptors that can cause transient vasodilation (widening of the blood vessels)